Item 8.01. Other Events.
On March 15, 2021, David, J. Moss, Chief Financial Officer of INmune Bio Inc., a
Nevada corporation (the "Company"), in accordance with Rule 10b5-1 of the
Securities Exchange act of 1934, as amended (the "Moss Plan") for trading
275,000 shares, or approximately 22.48% of the shares of the Company's common
stock owned by Mr. Moss. The Moss Plan commences on April 15, 2021 and
terminates on December 29, 2023.
On March 15, 2021, Raymond J. Tesi, Chief Executive Officer and a member of the
Board of Directors the Company, in accordance with Rule 10b5-1 of the Securities
Exchange act of 1934, as amended (the "Tesi Plan") for trading 120,000 shares,
or approximately 7.79% of the shares of the Company's common stock owned by Dr.
Tesi. The Tesi Plan commences on April 15, 2021 and terminates on April 14,
2022.
On March 15, 2021, Mark Lowdell, Chief Scientific Officer of the Company, in
accordance with Rule 10b5-1 of the Securities Exchange act of 1934, as amended
(the "Lowdell Plan") for trading 120,000 shares, or approximately 7.97% of the
shares of the Company's common stock owned by Dr. Lowdell. The Lowdell Plan
commences on April 15, 2021 and terminates on April 14, 2022.
Rule 10b5-1 plans permit corporate officers, directors and others to adopt
written, prearranged stock trading plans when they are not in possession of
material, non-public information. Using these plans, insiders may, consistent
with their personal asset diversification and tax planning strategies, exercise
pre-determined stock options and/or buy and sell a pre-determined number of
shares of the Company's stock over a period of time, regardless of whether the
insiders become aware of material, non-public information after adopting the
plans.
Transactions made under the Moss Plan, the Tesi Plan or the Lowdell Plan will be
reported to the Securities and Exchange Commission in accordance with applicable
securities laws, rules and regulations. Except as so required, the Company does
not undertake any obligation to update or report any modification, termination,
or other activity under the Moss Plan, Tesi Plan, Lowdell Plan or any plan that
may be adopted by other Officers or directors of the Company.
© Edgar Online, source Glimpses